The warning letter issued by the USFDA for Granules India’s Gagillapur unit highlights data integrity, quality and contamination issues and analysts do not expect a faster clearance for the plant.
The warning letter issued by the USFDA for Granules India’s Gagillapur unit highlights data integrity, quality and contamination issues and analysts do not expect a faster clearance for the plant.